High serum immunoglobulin D levels in systemic lupus erythematosus: more to be found?

• Published in: Clinical rheumatology 2023-04, Vol.42 (4), p.1069-1076
• Main Authors: Liang, Peifen, Huang, Qiuyan, Xu, Yanchun, Chen, Liling, Li, Jiajia, Xu, Anping, Yang, Qiongqiong
• Format: Article
• Language: English
• Subjects: Adult; Autoimmune diseases; Biomarkers; Cytokines; Disease; Enzyme-linked immunosorbent assay; Humans; Immunoglobulin D; Immunoglobulin E; Immunoglobulin G; Immunoglobulins; Inflammation; Kidney diseases; Lupus; Lupus Erythematosus, Systemic; Medicine; Medicine & Public Health; Original Article; Renal Insufficiency, Chronic; Rheumatology; Systemic lupus erythematosus
• ISSN: 0770-3198; 1434-9949
• DOI: 10.1007/s10067-022-06457-9

Introduction Many studies have shown that serum immunoglobulin D (IgD) is usually increased in autoimmune diseases. The potential role of IgD in systemic lupus erythematosus (SLE) is still unclear. Our study aimed to compare the serum IgD levels of SLE with different population and to evaluate the relationship between serum IgD and SLE. Methods Fifty SLE patients, 40 non-SLE chronic kidney disease (CKD) patients, and 50 healthy volunteers were enrolled in this study. Serum IgD levels were analyzed by ELISA assay and compared between groups. The correlation of serum IgD and SLE disease were evaluated. The ability of serum IgD to predict SLE was analyzed by graphing receiver operating characteristic curves. Results Serum IgD levels were significantly higher in SLE patients compared to non-SLE CKD and healthy controls (7436.1 ± 5862.1 vs. 4517.8 ± 5255.2 vs. 4180.4 ± 4881 ng/mL, p  = 0.01, p  = 0.002, respectively), and in patients with high SLE Disease Activity Index (SLEDAI) scores compared with those with low scores (8572.9 ± 5968.7 vs. 5020.4 ± 4972.5 ng/mL, p  = 0.044). High level of inflammatory cytokines and decreased circulating basophil counts were found in SLE patients ( p   0.05). Serum IgD was noninferior to IgG or IgE in discriminating SLE with an area under the curve of 0.672 (95% CI, 0.59–0.75). Conclusions Serum IgD levels are significantly elevated in SLE patients with high SLEDAI scores. Simultaneous occurrence of increased inflammatory cytokines and decreased basophil counts highlights the potential role of IgD-targets interaction in SLE pathogenesis. Key points • Total serum IgD levels were elevated in SLE patients. • High IgD levels were significantly higher in SLE patients with high SLEDAI scores. • The ability of serum IgD was equivalent to IgG or IgE in discriminating SLE from CKD and healthy adult.